Norachem
Norachem is a drug discovery company leveraging AI-based generative design to create novel drug molecules tailored for specific diseases such as cancers, CNS diseases like Alzheimer's, and aging. Their technology uses a combination of generative, deep learning, and physics-based models to explore near-infinite chemical space, optimizing for ease of synthesis, low toxicity, and high binding affinity. This approach enables faster, less expensive, and higher quality drug discovery compared to traditional methods. Norachem's multi-objective optimization can target multiple disease targets simultaneously, positioning the company as a leader in computational drug design with potential applications beyond pharmaceuticals.
Norachem
Norachem is a drug discovery company leveraging AI-based generative design to create novel drug molecules tailored for specific diseases such as cancers, CNS diseases like Alzheimer's, and aging. Their technology uses a combination of generative, deep learning, and physics-based models to explore near-infinite chemical space, optimizing for ease of synthesis, low toxicity, and high binding affinity. This approach enables faster, less expensive, and higher quality drug discovery compared to traditional methods. Norachem's multi-objective optimization can target multiple disease targets simultaneously, positioning the company as a leader in computational drug design with potential applications beyond pharmaceuticals.